
Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Articles by Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Targeted Treatment Options in Multiple MyelomaAugust 10th 2020
The Future of Multiple MyelomaAugust 10th 2020
A Look at the ENDURANCE TrialAugust 10th 2020
Maintenance Therapy in Multiple MyelomaAugust 10th 2020
Treatment Options in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Trials in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Advertisement
Advertisement
Trending on OncLive
1
Five Under 5: Top Oncology Videos for the Week of 8/31/26
2
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
3
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer
4
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
5










